ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STX Shield Therapeutics Plc

1.525
0.05 (3.39%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 3.39% 1.525 1.50 1.55 1.525 1.425 1.48 4,566,400 16:18:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.29 11.79M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.48p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £11.79 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.29.

Shield Therapeutics Share Discussion Threads

Showing 6401 to 6424 of 23275 messages
Chat Pages: Latest  259  258  257  256  255  254  253  252  251  250  249  248  Older
DateSubjectAuthorDiscuss
06/8/2020
17:20
Trying to read this as meaning that they had clearance to release this and this means a deal might be signed and presumably this is what the market thinks. This type of analysis would have taken them a month to do at the most but it’s been March since it was started.
crankyman
06/8/2020
17:17
It did not meet the target of noninferiority I’m either the ITT or the per protocol analysis. We had it reaching the target for the PP one before.
crankyman
06/8/2020
17:12
Ignore him, he is just cranky and bitter. Long term hold now, should be above the recent high soon imo Stay patient as always
ny boy
06/8/2020
16:55
>> cranky

Why do you say 'we now have a negative study in both populations' as I don't understand what you mean?

nobbygnome
06/8/2020
16:52
As I keep on saying, the main dish is to come yet........
nobbygnome
06/8/2020
16:39
Nobby - thanks for the heads up on SNG thread re STX, I've done quite nicely out of it - thanks again
boggy
06/8/2020
16:37
What a weird reaction. We now have a negative study in both populations. But yeah, carry on.
crankyman
06/8/2020
16:28
I've only got 9,750 here so will leave until a deal with the US. I had planned to slice more SNG/AVCT and buy more here and DNL but still think they've got a lot of upside and short term (next couple of weeks) so will wait and see how they pan out.
tickboo
06/8/2020
16:21
I remember buying at these levels thinking I was getting a bargain as the share price ridiculously dropped. And if anything STX is in better shape now !
peachie 74
06/8/2020
16:19
131p, the lowest ask on show, as I type.

f

fillipe
06/8/2020
16:04
lol 2000% in that old dog. I thought it had been taken out along with MTFB and shot.
waterloo01
06/8/2020
16:04
My point was more regarding independent clarification of the H2H could be behind the delay not that it increases the value of any deal that may or may not be already in place.
But yet another outstanding day on numerous fronts

best1467
06/8/2020
16:02
Val will do X4 what SNG did mate
northern66
06/8/2020
15:56
Happy times here. For all you that know about VAl .... you know ??
nick9013
06/8/2020
15:49
That’s good to know Nobby 👍🏼
peachie 74
06/8/2020
15:47
The HtH data was not submitted in the initial file to the FDA so is not on the current label. However, it will be submitted at the earliest possible opportunity (as told to me by the former CEO) so does have some value to a US partner. It should put a few more million on the upfront or an extra couple of % on the royalties!
nobbygnome
06/8/2020
15:47
Not slicing until its past 200
bobaxe1
06/8/2020
15:42
Would agree with an earlier post even though it was common knowledge that the H2H was a administrative error rather than efficacy it may be behind the hold up we may soon find out .Regarding valuation after deal if we get anywhere close to $50 million upfront its considerably north of £2
best1467
06/8/2020
15:41
Summer ends on Sept 23rd in the UK.
onceaday
06/8/2020
15:41
Nobby - Thanks for the heads up on this, I got in a little later after your tip at a spike and 102 but that seems a good move now - 20% in a few weeks and looks like lots more to come!
finster007
06/8/2020
15:41
You should also see some new broker upgrades tomorrow morning with amended price targets. Currently they are all c. £3.50
markinvestor
06/8/2020
15:36
On the former p24 the US deal they've stated an expected date of summer 2020, so that's between now and 31/8/20 by my calculations. Any US deal will have a significant upfront payment. The CEO has stated the likelihood of a deal is 'high'. The presentation also lays out plans for Q2 2020.
colin12345678
06/8/2020
15:33
I tend to agree; my new target with a half decent US deal is approaching £2 now!
nobbygnome
06/8/2020
15:32
Really good news but better still I reckon this will lead to the appointment of a US distributor soon and then we trade well north of £2.
czar
Chat Pages: Latest  259  258  257  256  255  254  253  252  251  250  249  248  Older